217 related articles for article (PubMed ID: 526392)
1. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
Thompson FD; Joekes AM; Hussein MM
Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of hypertension with labetalol.
Prichard BN; Boakes AJ; Hernández R
Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
[TBL] [Abstract][Full Text] [Related]
3. Labetalol in the treatment of patients with hypertension and renal function impairment.
Bailey RR
Br J Clin Pharmacol; 1979; 8(Suppl 2):135S-140S. PubMed ID: 526393
[No Abstract] [Full Text] [Related]
4. Double-blind trial of labetalol.
Kane J; Gregg I; Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
[TBL] [Abstract][Full Text] [Related]
5. Acute management of severe hypertension with oral labetalol.
Ghose RR
Br J Clin Pharmacol; 1979; 8(Suppl 2):189S-193S. PubMed ID: 526400
[TBL] [Abstract][Full Text] [Related]
6. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
Besterman EM; Spencer M
Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
[TBL] [Abstract][Full Text] [Related]
7. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
Joekes AM; Thompson FD
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
[TBL] [Abstract][Full Text] [Related]
8. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
Pedersen EB; Larsen JS
Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
[TBL] [Abstract][Full Text] [Related]
9. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
la Cour Petersen E; Kristensen BO
Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
[TBL] [Abstract][Full Text] [Related]
10. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
Rossi A; Ziacchi V; Lomanto B
Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
[TBL] [Abstract][Full Text] [Related]
11. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
Thompson FD; Joekes AM; Hussein MM
Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():129S-33S. PubMed ID: 26635153
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
Anavekar SN; Barter C; Adam WR; Doyle AE
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
[TBL] [Abstract][Full Text] [Related]
14. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
[TBL] [Abstract][Full Text] [Related]
15. Labetalol in long-term treatment of hypertension.
Prichard BN; Boakes AJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
[TBL] [Abstract][Full Text] [Related]
17. Labetalol and pindolol in the treatment of hypertension: a comparative study.
Romo M; Halttunen P; Saarinen P; Sarna S
Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
[TBL] [Abstract][Full Text] [Related]
18. Labetalol in resistant hypertension.
Dargie HJ; Dollery CT; Daniel J
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
[TBL] [Abstract][Full Text] [Related]
19. Labetalol in severe and resistant hypertension.
Williams LC; Murphy MJ; Parsons V
Br J Clin Pharmacol; 1979; 8(Suppl 2):143S-147S. PubMed ID: 526395
[TBL] [Abstract][Full Text] [Related]
20. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
Zech P; Pozet N; Sassard J; Vincent M
Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
